These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11432202)

  • 61. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
    Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
    Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8.
    Wang Q; Dziarski R; Kirschning CJ; Muzio M; Gupta D
    Infect Immun; 2001 Apr; 69(4):2270-6. PubMed ID: 11254583
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Unraveling innate immunity using large scale N-ethyl-N-nitrosourea mutagenesis.
    Hoebe K; Beutler B
    Tissue Antigens; 2005 May; 65(5):395-401. PubMed ID: 15853894
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protective T cell response against intracellular pathogens in the absence of Toll-like receptor signaling via myeloid differentiation factor 88.
    Kursar M; Mittrücker HW; Koch M; Köhler A; Herma M; Kaufmann SH
    Int Immunol; 2004 Mar; 16(3):415-21. PubMed ID: 14978015
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drosophila MyD88 is an adapter in the Toll signaling pathway.
    Horng T; Medzhitov R
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12654-8. PubMed ID: 11606776
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Toll-like receptors control activation of adaptive immune responses.
    Schnare M; Barton GM; Holt AC; Takeda K; Akira S; Medzhitov R
    Nat Immunol; 2001 Oct; 2(10):947-50. PubMed ID: 11547333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genetic approaches to the study of Toll-like receptor function.
    Takeuchi O; Akira S
    Microbes Infect; 2002 Jul; 4(9):887-95. PubMed ID: 12106781
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease.
    Mancuso G; Midiri A; Beninati C; Biondo C; Galbo R; Akira S; Henneke P; Golenbock D; Teti G
    J Immunol; 2004 May; 172(10):6324-9. PubMed ID: 15128822
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IL-1 receptor-associated kinase and low molecular weight GTPase RhoA signal molecules are required for bacterial lipopolysaccharide-induced cytokine gene transcription.
    Chen LY; Zuraw BL; Liu FT; Huang S; Pan ZK
    J Immunol; 2002 Oct; 169(7):3934-9. PubMed ID: 12244193
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Role of toll-like receptor in immunological defence mechanism ].
    Uematsu S; Akira S
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):355-61. PubMed ID: 15768602
    [No Abstract]   [Full Text] [Related]  

  • 72. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism.
    Adachi K; Tsutsui H; Kashiwamura S; Seki E; Nakano H; Takeuchi O; Takeda K; Okumura K; Van Kaer L; Okamura H; Akira S; Nakanishi K
    J Immunol; 2001 Nov; 167(10):5928-34. PubMed ID: 11698470
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans.
    Quesniaux VJ; Nicolle DM; Torres D; Kremer L; Guérardel Y; Nigou J; Puzo G; Erard F; Ryffel B
    J Immunol; 2004 Apr; 172(7):4425-34. PubMed ID: 15034058
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Congenital components of immunity: Toll-like receptors in the normal state and in immunopathology].
    Koval'chuk LV; Khoreva MV; Varivoda AS
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (4):96-104. PubMed ID: 16146239
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
    Medzhitov R; Preston-Hurlburt P; Kopp E; Stadlen A; Chen C; Ghosh S; Janeway CA
    Mol Cell; 1998 Aug; 2(2):253-8. PubMed ID: 9734363
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
    Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
    J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
    Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
    J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
    Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
    J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunology: a block at the toll gate.
    Mak TW; Yeh WC
    Nature; 2002 Aug; 418(6900):835-6. PubMed ID: 12192398
    [No Abstract]   [Full Text] [Related]  

  • 80. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.
    Scanga CA; Aliberti J; Jankovic D; Tilloy F; Bennouna S; Denkers EY; Medzhitov R; Sher A
    J Immunol; 2002 Jun; 168(12):5997-6001. PubMed ID: 12055206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.